These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Factors Influencing Cyst Infection in Autosomal Dominant Polycystic Kidney Disease. Suwabe T, Ubara Y, Hayami N, Yamanouchi M, Hiramatsu R, Sumida K, Sawa N, Sekine A, Kawada M, Hasegawa E, Hoshino J, Takaichi K. Nephron; 2019; 141(2):75-86. PubMed ID: 30513520 [Abstract] [Full Text] [Related]
3. Cyst infections in patients with autosomal dominant polycystic kidney disease. Sallée M, Rafat C, Zahar JR, Paulmier B, Grünfeld JP, Knebelmann B, Fakhouri F. Clin J Am Soc Nephrol; 2009 Jul; 4(7):1183-9. PubMed ID: 19470662 [Abstract] [Full Text] [Related]
4. Cyst infection in autosomal dominant polycystic kidney disease: penetration of meropenem into infected cysts. Hamanoue S, Suwabe T, Ubara Y, Kikuchi K, Hazue R, Mise K, Ueno T, Takaichi K, Matsumoto K, Morita K. BMC Nephrol; 2018 Oct 19; 19(1):272. PubMed ID: 30340529 [Abstract] [Full Text] [Related]
5. Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease. Bleeker-Rovers CP, de Sévaux RG, van Hamersvelt HW, Corstens FH, Oyen WJ. Am J Kidney Dis; 2003 Jun 19; 41(6):E18-21. PubMed ID: 12776306 [Abstract] [Full Text] [Related]
6. Cyst infection in autosomal dominant polycystic kidney disease: causative microorganisms and susceptibility to lipid-soluble antibiotics. Suwabe T, Araoka H, Ubara Y, Kikuchi K, Hazue R, Mise K, Hamanoue S, Ueno T, Sumida K, Hayami N, Hoshino J, Imafuku A, Kawada M, Hiramatsu R, Hasegawa E, Sawa N, Takaichi K. Eur J Clin Microbiol Infect Dis; 2015 Jul 19; 34(7):1369-79. PubMed ID: 25851811 [Abstract] [Full Text] [Related]
7. 18F-FDG PET/CT demonstrated renal and hepatic cyst infection in a patient with autosomal dominant polycystic kidney disease. Albano D, Bosio G, Bertagna F. Nucl Med Rev Cent East Eur; 2016 Jul 19; 19(B):26-28. PubMed ID: 27813615 [Abstract] [Full Text] [Related]
8. Carbohydrate antigen 19-9 as a diagnostic marker for hepatic cyst infection in autosomal dominant polycystic kidney disease. Kanaan N, Goffin E, Pirson Y, Devuyst O, Hassoun Z. Am J Kidney Dis; 2010 May 19; 55(5):916-22. PubMed ID: 20189277 [Abstract] [Full Text] [Related]
15. Hepatic Cyst Infection During Use of the Somatostatin Analog Lanreotide in Autosomal Dominant Polycystic Kidney Disease: An Interim Analysis of the Randomized Open-Label Multicenter DIPAK-1 Study. Lantinga MA, D'Agnolo HM, Casteleijn NF, de Fijter JW, Meijer E, Messchendorp AL, Peters DJ, Salih M, Spithoven EM, Soonawala D, Visser FW, Wetzels JF, Zietse R, Drenth JP, Gansevoort RT, DIPAK Consortium. Drug Saf; 2017 Feb 19; 40(2):153-167. PubMed ID: 27995519 [Abstract] [Full Text] [Related]
16. Clinical experience with white blood cell-PET/CT in autosomal dominant polycystic kidney disease patients with suspected cyst infection: A prospective case series. Kim H, Oh YK, Park HC, Park S, Lee S, Lee HY, Hwang YH, Ahn C. Nephrology (Carlton); 2018 Jul 19; 23(7):661-668. PubMed ID: 28565035 [Abstract] [Full Text] [Related]
18. Ruptured giant liver cyst: a rare cause of acute abdomen in a haemodialysis patient with autosomal dominant polycystic kidney disease. Carels RA, van Bommel EF. Neth J Med; 2002 Oct 19; 60(9):363-5. PubMed ID: 12572709 [Abstract] [Full Text] [Related]
19. Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort. Bae KT, Zhu F, Chapman AB, Torres VE, Grantham JJ, Guay-Woodford LM, Baumgarten DA, King BF, Wetzel LH, Kenney PJ, Brummer ME, Bennett WM, Klahr S, Meyers CM, Zhang X, Thompson PA, Miller JP, Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP). Clin J Am Soc Nephrol; 2006 Jan 19; 1(1):64-9. PubMed ID: 17699192 [Abstract] [Full Text] [Related]